These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6360575)
41. Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials. Scheidt S; Frishman WH; Packer M; Mehta J; Parodi O; Subramanian VB Am J Cardiol; 1982 Nov; 50(5):1185-90. PubMed ID: 6814226 [TBL] [Abstract][Full Text] [Related]
42. Efficacy of nicardipine in angina pectoris. Thomas MG; Sander GE; Given MB; Quiroz AC; Roffidal LE; Giles TD J Clin Pharmacol; 1990 Jan; 30(1):24-8. PubMed ID: 2406298 [TBL] [Abstract][Full Text] [Related]
43. Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine. Crake T; Mulcahy D; Wright C; Fox K Eur Heart J; 1988 Nov; 9(11):1200-5. PubMed ID: 3069466 [TBL] [Abstract][Full Text] [Related]
44. An objective comparison of verapamil and placebo in chronic stable angina. Balasubramanian V; Raftery EB Clin Exp Pharmacol Physiol Suppl; 1982; 6():51-61. PubMed ID: 6811177 [TBL] [Abstract][Full Text] [Related]
45. Effect of bepridil in patients with chronic stable angina: results of a multicenter trial. Hill JA; O'Brien JT; Alpert JS; Gore JM; Zusman RM; Christensen D; Boucher CA; Vetrovec G; Borer JS; Friedman C Circulation; 1985 Jan; 71(1):98-103. PubMed ID: 3880521 [TBL] [Abstract][Full Text] [Related]
46. The efficacy and safety of high-dose verapamil and diltiazem in the long-term treatment of stable exertional angina. Weiner DA; McCabe CH; Cutler SS; Ryan TJ; Klein MD Clin Cardiol; 1984 Dec; 7(12):648-53. PubMed ID: 6391771 [TBL] [Abstract][Full Text] [Related]
47. Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit. Parodi O; Simonetti I; Michelassi C; Carpeggiani C; Biagini A; L'Abbate A; Maseri A Am J Cardiol; 1986 Apr; 57(11):899-906. PubMed ID: 3083668 [TBL] [Abstract][Full Text] [Related]
48. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes. Friedensohn A; Meshulam R; Schlesinger Z Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827 [TBL] [Abstract][Full Text] [Related]
49. Short-term efficacy of oral verapamil in rest angina. A double-blind placebo controlled trial in CCU patients. Mehta J; Pepine CJ; Day M; Guerrero JR; Conti CR Am J Med; 1981 Dec; 71(6):977-82. PubMed ID: 7032291 [TBL] [Abstract][Full Text] [Related]
50. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol. Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223 [TBL] [Abstract][Full Text] [Related]
52. A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris. Hopkinson ND; Hui KP; Smith MP; Hollinrake K Eur Heart J; 1991 Dec; 12(12):1273-7. PubMed ID: 1778191 [TBL] [Abstract][Full Text] [Related]
53. Age-related changes of antianginal effects of verapamil in patients with stable effort angina. A medium term randomized double-blind placebo controlled trial. Acanfora D; De Caprio L; Di Palma A; Lirato C; Parlati S; Furgi G; Guerra N; Odierna L; Nicolino A; Rengo F G Ital Cardiol; 1993 May; 23(5):451-8. PubMed ID: 8339870 [TBL] [Abstract][Full Text] [Related]
54. Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina. Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB J Am Coll Cardiol; 1987 Mar; 9(3):615-21. PubMed ID: 3102585 [TBL] [Abstract][Full Text] [Related]
55. Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. Parodi O; Maseri A; Simonetti I Br Heart J; 1979 Feb; 41(2):167-74. PubMed ID: 371644 [TBL] [Abstract][Full Text] [Related]
56. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group. Nordlander R; Walter M Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569 [TBL] [Abstract][Full Text] [Related]
57. Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report. Sandberg M; Foale RA Drugs; 1988; 35 Suppl 4():51-5. PubMed ID: 3132360 [TBL] [Abstract][Full Text] [Related]
59. A comparison of once and twice daily atenolol for angina pectoris. Boyle RM; Bray CL; Naqvi N; Croxson RS; Cruickshank JM Int J Cardiol; 1983 Apr; 3(1):25-35. PubMed ID: 6343259 [TBL] [Abstract][Full Text] [Related]